Standout Papers

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity... 2010 2026 2015 2020 1.5k
  1. The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate (2010)
    Patrick S. Ward, Jay Patel et al. Cancer Cell
  2. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells (2017)
    Ly Vu, Brian F. Pickering et al. Nature Medicine

Immediate Impact

19 by Nobel laureates 44 from Science/Nature 102 standout
Sub-graph 1 of 19

Citing Papers

H3K4me3 regulates RNA polymerase II promoter-proximal pause-release
2023 StandoutNature
Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia
2022 Standout
14 intermediate papers

Works of Martin Carroll being referenced

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells
2014
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
2010 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Martin Carroll 4600 6716 2112 2581 196 11.5k
Stephen D. Nimer 6656 7352 2721 3321 238 14.3k
Paresh Vyas 4947 4372 1774 1304 229 9.2k
Justus Duyster 3447 3853 2148 2356 255 8.8k
Omar Abdel‐Wahab 7174 10650 5159 2109 296 18.0k
Dolors Colomer 2665 5039 4833 3036 277 11.7k
D. Gary Gilliland 8009 8287 4083 2754 126 15.9k
Stefan Fröhling 5414 5450 1958 2126 205 10.8k
Azra Raza 8686 5409 3501 1538 273 12.1k
Bruno Quesnel 3565 3460 1884 2601 199 7.9k
Christine Chomienne 6721 9934 1922 1300 246 12.6k

All Works

Loading papers...

Rankless by CCL
2026